Afrigather SINGAPORE, June 19, 2024 – (NewMediaWire) – Cellular-health Community Options [‘MaNaDr’] (Nasdaq: MNDR), a number one Asia-Pacific telehealth supplier, as we speak introduced up to date pricing for its medical weight administration program, enhancing the affordability and accessibility of GLP-1 (glucagon-like peptide-1) receptor agonist medicines within the Asia-Pacific (APAC) area.
This system, designed to stem the rising prevalence of weight problems in Singapore and throughout the APAC area, is believed to be among the many most competitively priced within the area. Because of this, MaNaDr expects this system can have a big adoption price and supply significant incremental income beginning within the third quarter of the present calendar 12 months.
“Leveraging our sturdy partnerships, we provide a variety of GLP-1 medicines instantly sourced from the main pharmaceutical innovators,” mentioned Ms. Regulation Pei Bei, Chief Enterprise Officer. “This implies sufferers have entry to the unique, brand-name GLP-1 injections, guaranteeing the best high quality and confirmed outcomes.
“We have negotiated aggressive pricing with these main pharmaceutical producers, permitting us to supply authentic GLP-1 medicines at pricing beginning at lower than US$10 per day. This low pricing makes these therapies a sensible possibility for many weight administration sufferers.”
Co-CEO Dr. Siaw Tung Yeng, PBM, Senior Guide Household Doctor, added, “Telehealth consultations create a secure and cozy setting for weight administration discussions. That is particularly useful for people who could expertise shyness, social nervousness, or worry in a standard setting. Telehealth empowers these sufferers to brazenly focus on their weight reduction targets and challenges, fostering a supportive basis for his or her journey.”
Marketed with the tagline, “It is Okay to be Not Okay,” the MaNaDr program is among the many few of its form within the APAC area to supply a one-stop supply for sufferers’ weight administration wants.
Providers offered embrace:
Medical Intervention. Sufferers can seek the advice of with medical doctors for customized medical recommendation, together with the suitability of utilizing GLP-1 medicines equivalent to Semaglutide (model names Wegovy and Rybelsus), Liraglutide (Saxenda), Dulaglutide (Trucility), or different prescription weight reduction medicines.
Psychological/Emotional Assist. Sufferers obtain ongoing psychological and emotional help from a devoted private care guide and coach, who will set achievable targets, information them via challenges, and have a good time their successes.
Dietary Steering. Sufferers can work with registered dietitians to develop a customized, sustainable consuming plan.
Health Experience. Sufferers can seek the advice of with licensed train instructors to create an train program that matches their wants and preferences.
24/7 Availability. Sufferers can contact a member of their healthcare group to debate quick issues across the clock.
Knowledge-Pushed Monitoring. Sufferers can observe their progress with a user-friendly private way of life diary that screens meals, bodily exercise, and physique measurements.
Neighborhood Discussion board. The in-app discussion board gives an extra layer of peer help, providing anonymity for people hesitant to share brazenly in a standard group setting.
Easy Refills. Sufferers can refill their prescriptions rapidly and simply inside the MaNaDr app.
In-Clinic Possibility. Sufferers preferring in-person visits could schedule them and obtain complete bodily evaluations.
“Many weight administration options out there as we speak finally fail – partly as a result of sufferers don’t obtain the assistance they want, once they want it,” mentioned MaNaDr co-CEO Dr. Rachel Teoh Pui Pui, PBM, Household Doctor. “Our program addresses these challenges by prioritizing the three parts we consider are important to profitable weight reduction: efficient prescription medicines, 24/7 psychological well being help, and customized dietary and health steering.
“A number of latest research exhibit that GLP-1 medicines like Saxenda might help most sufferers lose 5 to 10 % of their physique weight inside an affordable time period,” said Dr. Teoh. “Ought to sufferers expertise unintended effects from utilizing such medicines, we are going to contemplate providing different medicines, each prescription and over-the-counter, that can finest assist sufferers obtain a secure and profitable final result of their weight administration targets.”
Equally essential, she added, is the provision {of professional} psychological well being help for weight administration sufferers. “Typically underestimated, and even ignored, is the worry, isolation, cravings, and disgrace skilled by many sufferers with weight administration points. We deal with these wants by guaranteeing that sufferers have a devoted private care guide and coach who’s completely conversant in a affected person’s wants, and by making knowledgeable out there to seek the advice of with sufferers on a 24/7 foundation. No affected person in our program will ever have their wants ignored once they need assistance.”
Dr. Teoh mentioned the MaNaDr weight administration program tailors a selected dietary and health program for every affected person based mostly on their sensible wants and talents. “Sufferers can observe dietary and health targets higher when these targets are achievable. Our suppliers work onerous to verify this occurs.”
Dr. Siaw added, “We’re excited to launch this complete weight administration program. By combining entry to medical professionals, extremely efficient weight reduction medicines, dietary steering, and health experience, all inside one app, we’re empowering people to attain their targets holistically and sustainably.”
About Cellular-health Community Options Pte Ltd [MaNaDr]
Ranked #41 within the Monetary Instances 2024 itemizing of 500 Excessive-growth Asia-Pacific Corporations, ManNaDr is the primary telehealth supplier from the Asia-Pacific area to be listed within the US (Nasdaq). By way of its MaNaDr platform app, it gives customized and dependable medical consideration to customers worldwide. The platform permits the group of healthcare suppliers to have a broader attain to customers via digital clinics with none start-up prices and the power to hook up with a worldwide community of peer-to-peer help teams and companions. The vary of seamless and hassle-free telehealth options contains teleconsultation companies, prescription success and different customized companies equivalent to weight administration applications and gender-specific care. For extra info, please go to https://manadr.com. For Investor Relations, please go to https://investors.manadr.com.
Contemplating GLP-1 medicines for weight administration. Be taught extra about this selection and discover if it is best for you. Go to our web site https://manadr.com/weight-management or schedule a handy teleconsultation with our specialist medical doctors via the MaNaDr app.
FORWARD-LOOKING STATEMENTS
Sure statements contained on this press launch about future expectations, plans and prospects, in addition to another statements concerning issues that aren’t historic information, could represent “forward-looking statements” inside the which means of the Personal Securities Litigation Reform Act of 1995. Traders are cautioned to not place undue reliance upon any forward-looking statements on this press launch. Any forward-looking statements contained on this press launch converse solely as of the date hereof, and Cellular-health Community Options particularly disclaims any obligation to replace any forward-looking assertion, whether or not on account of new info, future occasions or in any other case, besides as required by legislation.
For media inquiries, please contact:
Cellular-health Community Options Pte Ltd
Workplace: +65 6222 5223
E-mail: support@manadr.com,investors@manadr.com
Investor Relations Inquiries:
Skyline Company Communications Group, LLC
Scott Powell, President
Workplace: (646) 893 5835
E-mail: info@skylineccg.com
Matter: Drug Approval
Supply: Mobile-health Network Solutions Pte Ltd
Sectors: Style & Attire, Media & Advertising, Retail & eCommerce, Meals & Beverage, Wi-fi, Apps, Healthcare & Pharm
http://www.acnnewswire.com
From the Asia Company Information Community
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Company Information Community.
